Glycation, receptor-mediated cell activation and vascular complications of diabetes
Open Access
- 1 May 2004
- journal article
- Published by SAGE Publications in Diabetes and Vascular Disease Research
- Vol. 1 (1) , 21-22
- https://doi.org/10.3132/dvdr.2004.002
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Divergent Pathways of Gene Expression Are Activated by the RAGE Ligands S100b and AGE-BSADiabetes, 2004
- Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 ProteinJournal of Biological Chemistry, 2004
- Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kineticsAnalytical Biochemistry, 2003
- Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometryBiochemical Journal, 2003
- High mobility group 1 B‐box mediates activation of human endotheliumJournal of Internal Medicine, 2003
- RAGE Drives the Development of Glomerulosclerosis and Implicates Podocyte Activation in the Pathogenesis of Diabetic NephropathyThe American Journal of Pathology, 2003
- Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injuryBiochemical Journal, 2003
- Acute Hyperglycemia Causes Intracellular Formation of CML and Activation of ras, p42/44 MAPK, and Nuclear Factor κB in PBMCsDiabetes, 2003
- Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing miceJournal of Clinical Investigation, 2001
- RAGE Mediates a Novel Proinflammatory Axis: A Central Cell Surface Receptor for S100/Calgranulin PolypeptidesPublished by Elsevier ,1999